Correlation Between Inhibrx and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Inhibrx and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Verrica Pharmaceuticals.
Diversification Opportunities for Inhibrx and Verrica Pharmaceuticals
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Inhibrx and Verrica is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Inhibrx i.e., Inhibrx and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibrx and Verrica Pharmaceuticals
Given the investment horizon of 90 days Inhibrx is expected to generate 0.42 times more return on investment than Verrica Pharmaceuticals. However, Inhibrx is 2.4 times less risky than Verrica Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 1,721 in Inhibrx on September 2, 2024 and sell it today you would lose (195.00) from holding Inhibrx or give up 11.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| Inhibrx |
| Verrica Pharmaceuticals |
Inhibrx and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Verrica Pharmaceuticals
The main advantage of trading using opposite Inhibrx and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |